Table 3.
Relationship between CTC levels and clinicopathological characteristics in 50 patients.
| CTC status | Lymph node status | Clinical stage | Ki-67 levels | Hormone receptor | |||||
|---|---|---|---|---|---|---|---|---|---|
| No | Yes | Ⅰ/Ⅱ | III | ≤30% | >30% | Negative | Positive | ||
| CellSearch system | |||||||||
| Positive | 2 (14.3%) | 13 (36.1%) | 9 (25.7%) | 6 (40.0%) | 2 (25.0%) | 13 (31.0%) | 8 (29.6%) | 7 (30.4%) | |
| Negative | 12 (85.7%) | 23 (63.9%) | 26 (74.3%) | 9 (60.0%) | 6 (75.0%) | 29 (69.0%) | 19 (70.4%) | 16 (69.6%) | |
| χ2 value | 1.365 | 0.454 | 0 | 0.004 | |||||
| P value | 0.243 | 0.501 | 1 | 0.951 | |||||
| TUMORFISHER system | |||||||||
| Positive | 6 (42.9%) | 21 (58.3%) | 18 (51.4%) | 9 (60.0%) | 6 (75.0%) | 21 (50.0%) | 14 (51.9%) | 13 (56.5%) | |
| Negative | 8 (57.1%) | 15 (41.7%) | 17 (48.6%) | 6 (40.0%) | 2 (25.0%) | 21 (50.0%) | 13 (48.1%) | 10 (43.5%) | |
| χ2value | 0.972 | 0.311 | 0.834 | 0.109 | |||||
| p value | 0.324 | 0.577 | 0.361 | 0.741 | |||||